These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12592063)

  • 21. Outcomes of high initial daily doses of gonadotropin in patients with poor ovarian reserve.
    Chou LL; Hwu YM; Lin MH; Lin SY; Lee RK
    Taiwan J Obstet Gynecol; 2010 Dec; 49(4):442-8. PubMed ID: 21199746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
    Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R
    Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controversies in assisted reproduction: oocyte donation. Protocols for egg donation.
    Barri PN; Coroleu B; Martinez F; Parera N; Boada M; Veiga A
    J Assist Reprod Genet; 1994 Nov; 11(10):489-91. PubMed ID: 7663102
    [No Abstract]   [Full Text] [Related]  

  • 24. Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome.
    Gustofson RL; Segars JH; Larsen FW
    Hum Reprod; 2006 Nov; 21(11):2830-7. PubMed ID: 16966348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a detrimental effect of higher gonadotrophin dose on clinical pregnancy rate in normo-responders undergoing ART with long protocol?
    Yilmaz N; Yilmaz S; Inal H; Gorkem U; Seckin B; Turkkani A; Gulerman C
    Arch Gynecol Obstet; 2013 May; 287(5):1039-44. PubMed ID: 23233291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triggering with GnRH agonist in oocyte-donation cycles: oestradiol monitoring is not necessary during ovarian stimulation.
    Castillo JC; Dolz M; Moreno J; Gijón L; Ferrer R; Ferrero E; Bonilla-Musoles F
    Reprod Biomed Online; 2012 Feb; 24(2):247-50. PubMed ID: 22196891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated E2: oocyte ratio in women undergoing IVF and tubal ET. Correlation with a decrease in the implantation rate.
    Yang JH; Chen HF; Lien YR; Chen SU; Ho HN; Yang YS
    J Reprod Med; 2001 May; 46(5):434-8. PubMed ID: 11396368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three hundred cycles of oocyte donation at the University of Southern California: assessing the effect of age and infertility diagnosis on pregnancy and implantation rates.
    Sauer MV; Paulson RJ; Ary BA; Lobo RA
    J Assist Reprod Genet; 1994 Feb; 11(2):92-6. PubMed ID: 7819708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: comparison of r-FSH alone and in combination with r-LH.
    Levi-Setti PE; Cavagna M; Bulletti C
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):212-6. PubMed ID: 16377062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome.
    Sahu B; Ozturk O; Ranierri M; Serhal P
    Arch Gynecol Obstet; 2008 Mar; 277(3):239-44. PubMed ID: 17899140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment with oral contraceptive pills does not influence the pregnancy rate in the long leuprolide acetate protocol.
    Bozdag G; Esinler I; Yaralı H
    Gynecol Obstet Invest; 2012; 73(1):53-7. PubMed ID: 22133574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Day 4 estradiol levels predict pregnancy success in women undergoing controlled ovarian hyperstimulation for IVF.
    Phelps JY; Levine AS; Hickman TN; Zacur HA; Wallach EE; Hinton EL
    Fertil Steril; 1998 Jun; 69(6):1015-9. PubMed ID: 9627286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oocyte and embryo quality after coasting: the experience from oocyte donation.
    Isaza V; García-Velasco JA; Aragonés M; Remohí J; Simón C; Pellicer A
    Hum Reprod; 2002 Jul; 17(7):1777-82. PubMed ID: 12093839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic value assessment of the early response of blood estradiol, FSH, and LH using leuprolide acetate during ovarian hyperstimulation in assisted reproduction].
    Sondón García Z; Alvarado A; Peraza Briones C; González Sánchez R; Jiménez Perea L
    Ginecol Obstet Mex; 2001 Feb; 69():65-71. PubMed ID: 11339176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A study of the controlled ovarian hyperstimulation using GnRH agonist and pure FSH in in vitro fertilization-embryo transfer and gamete intrafallopian transfer program].
    Usui A
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1431-8. PubMed ID: 2511261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcome of cycles with oocyte degeneration after intracytoplasmic sperm injection.
    Liu L; Cai J; Li P; Jiang X; Ren J
    Syst Biol Reprod Med; 2017 Apr; 63(2):113-119. PubMed ID: 28151020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization.
    Hsieh YY; Chang CC; Tsai HD
    Taiwan J Obstet Gynecol; 2008 Mar; 47(1):66-74. PubMed ID: 18400585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolated polycystic morphology in ovum donors predicts response to ovarian stimulation.
    Wong IL; Morris RS; Lobo RA; Paulson RJ; Sauer MV
    Hum Reprod; 1995 Mar; 10(3):524-8. PubMed ID: 7782426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.